A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women
Launched by SECOND AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY · Sep 12, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help predict if pregnant women will have a successful vaginal delivery. By using MRI scans, researchers can create a 3D model of the woman's pelvis and the baby's head. They will then combine this imaging data with artificial intelligence to develop a tool that can more accurately estimate the chances of a vaginal delivery being successful.
To participate in this study, women need to be at full term in their pregnancy and carrying a single baby that is positioned head-first, as this is important for a vaginal delivery. The trial is not yet recruiting participants, but those who qualify can expect to undergo MRI scans and contribute to important research that could help future mothers. It’s also important to note that women with certain medical issues, multiple pregnancies, or specific complications will not be eligible to join the study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Full-term.
- • Single fetus, head first.
- • Pregnant women have vaginal couvade wishes.
- • Complete clinical data of pregnant women.
- Exclusion Criteria:
- • Pregnancy with serious medical and surgical diseases.
- • Abnormal fetal position (such as transverse, breech, etc.).
- • Twin or multiple pregnancies.
- • Vaginal couvade contraindications such as placenta previa.
About Second Affiliated Hospital Of Wenzhou Medical University
The Second Affiliated Hospital of Wenzhou Medical University is a leading clinical research institution in China, renowned for its commitment to advancing medical knowledge and improving patient care. As a prominent teaching hospital, it integrates clinical practice with innovative research and education, fostering a collaborative environment for healthcare professionals. The hospital is equipped with state-of-the-art facilities and a diverse range of specialized departments, enabling it to conduct comprehensive clinical trials across various medical fields. Its mission is to enhance healthcare outcomes through rigorous scientific inquiry and to contribute to the global body of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wenzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported